These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


950 related items for PubMed ID: 25159928

  • 1. Clinical and scientific aspects of muscle-specific tyrosine kinase-related myasthenia gravis.
    Reddel SW, Morsch M, Phillips WD.
    Curr Opin Neurol; 2014 Oct; 27(5):558-65. PubMed ID: 25159928
    [Abstract] [Full Text] [Related]

  • 2. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
    Klooster R, Plomp JJ, Huijbers MG, Niks EH, Straasheijm KR, Detmers FJ, Hermans PW, Sleijpen K, Verrips A, Losen M, Martinez-Martinez P, De Baets MH, van der Maarel SM, Verschuuren JJ.
    Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
    [Abstract] [Full Text] [Related]

  • 3. Passive and active immunization models of MuSK-Ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects.
    Viegas S, Jacobson L, Waters P, Cossins J, Jacob S, Leite MI, Webster R, Vincent A.
    Exp Neurol; 2012 Apr; 234(2):506-12. PubMed ID: 22326541
    [Abstract] [Full Text] [Related]

  • 4. Update on muscle-specific tyrosine kinase antibody positive myasthenia gravis.
    Guptill JT, Sanders DB.
    Curr Opin Neurol; 2010 Oct; 23(5):530-5. PubMed ID: 20613516
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pre- and postsynaptic neuromuscular junction abnormalities in musk myasthenia.
    Niks EH, Kuks JB, Wokke JH, Veldman H, Bakker E, Verschuuren JJ, Plomp JJ.
    Muscle Nerve; 2010 Aug; 42(2):283-8. PubMed ID: 20544919
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
    Evoli A, Tonali PA, Padua L, Monaco ML, Scuderi F, Batocchi AP, Marino M, Bartoccioni E.
    Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
    [Abstract] [Full Text] [Related]

  • 14. [Clinical features of myasthenia related with autoantibodies to muscle specific tyrosine kinase (MuSK)].
    Sanadze AG, Sidnev DV, Karganov MIu.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010 Oct; 110(12):72-6. PubMed ID: 21311492
    [Abstract] [Full Text] [Related]

  • 15. [Myasthenia gravis induced by autoantibodies against MuSK].
    Shigemoto K, Konishi T, Ohta M.
    Nihon Rinsho; 2008 Jun; 66(6):1149-54. PubMed ID: 18540361
    [Abstract] [Full Text] [Related]

  • 16. Myasthenia and the neuromuscular junction.
    Gilhus NE.
    Curr Opin Neurol; 2012 Oct; 25(5):523-9. PubMed ID: 22892950
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 48.